Lessons from COVID-19 Pandemic : A Successful Policy and Practice by Pasteur Institute of Iran
The present study aims to provide an insight to the comprehensive efforts of Pasteur Institute of Iran (PII) regarding COVID-19 management, research, achievements, and vaccine production, though there are many challenges. The relevant literature review was investigated through national and international database and also reports from the related research departments. Six strategies were taken by PII to manage the pandemic of COVID-19. While this pandemic has been hopefully controlled, SARS-CoV-2 could still be a potential threat. Therefore, COVID-19 data management and updated studies, as well as long-term safety and efficacy of the SARS-CoV-2 vaccines are still on the agenda.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:28 |
|---|---|
| Enthalten in: |
Iranian biomedical journal - 28(2024), 1 vom: 01. Jan., Seite 1-7 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Sadat Larijani, Mona [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
COVID-19 |
|---|
| Anmerkungen: |
Date Completed 19.03.2024 Date Revised 06.04.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.61186/ibj.3964 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM367145847 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM367145847 | ||
| 003 | DE-627 | ||
| 005 | 20240406232118.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240115s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.61186/ibj.3964 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1367.xml |
| 035 | |a (DE-627)NLM367145847 | ||
| 035 | |a (NLM)38224028 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Sadat Larijani, Mona |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Lessons from COVID-19 Pandemic |b A Successful Policy and Practice by Pasteur Institute of Iran |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 19.03.2024 | ||
| 500 | |a Date Revised 06.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a The present study aims to provide an insight to the comprehensive efforts of Pasteur Institute of Iran (PII) regarding COVID-19 management, research, achievements, and vaccine production, though there are many challenges. The relevant literature review was investigated through national and international database and also reports from the related research departments. Six strategies were taken by PII to manage the pandemic of COVID-19. While this pandemic has been hopefully controlled, SARS-CoV-2 could still be a potential threat. Therefore, COVID-19 data management and updated studies, as well as long-term safety and efficacy of the SARS-CoV-2 vaccines are still on the agenda | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Pandemics | |
| 650 | 4 | |a Vaccines | |
| 650 | 7 | |a COVID-19 Vaccines |2 NLM | |
| 650 | 7 | |a Viral Vaccines |2 NLM | |
| 700 | 1 | |a Biglari, Alireza |e verfasserin |4 aut | |
| 700 | 1 | |a Sorouri, Rahim |e verfasserin |4 aut | |
| 700 | 1 | |a Salehi-Vaziri, Mostafa |e verfasserin |4 aut | |
| 700 | 1 | |a Doroud, Delaram |e verfasserin |4 aut | |
| 700 | 1 | |a Azadmanesh, Keyhan |e verfasserin |4 aut | |
| 700 | 1 | |a Fotouhi, Fatemeh |e verfasserin |4 aut | |
| 700 | 1 | |a Mostafavi, Ehsan |e verfasserin |4 aut | |
| 700 | 1 | |a Ramezani, Amitis |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Iranian biomedical journal |d 1998 |g 28(2024), 1 vom: 01. Jan., Seite 1-7 |w (DE-627)NLM09752722X |x 2008-823X |7 nnns |
| 773 | 1 | 8 | |g volume:28 |g year:2024 |g number:1 |g day:01 |g month:01 |g pages:1-7 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.61186/ibj.3964 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 28 |j 2024 |e 1 |b 01 |c 01 |h 1-7 | ||